title: RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis.
abstract: OBJECTIVE
  RDP58 is a novel anti-inflammatory peptide that inhibits TNF synthesis and upregulates heme oxygenase-1. RDP58 therapy was evaluated in the dextran sodium sulphate (DSS) model of chronic colitis.
  
  
  METHODS
  Colitis was induced by giving DSS to mice (n = 8 animals/group). Toxicity studies were done in Rhesus monkeys (n = 5), dogs (n = 3) and mice (n = 10).
  
  
  METHODS
  In colitis, mice were treated with p.o. vehicle (saline), RDP58 (5 and 10 mg/kg/day) or 5-ASA (50 mg/kg/day).
  
  
  METHODS
  Disease activity index (DAI) was used as the endpoint of efficacy.
  
  
  RESULTS
  RDP58 therapy significantly reduced DAI and histological scores in all animals. DAI scores in RDP58 treated animals declined faster than 5-ASA. RDP58 at 5 or 10 mg/ kg/day significantly reduced DAI compared to 5-ASA. RDP58 significantly reduced acute, chronic and total inflammation scores. It enhanced re-epithelialization by reducing crypt scores. RDP58 was not bioavailable and was well tolerated.
  
  
  CONCLUSIONS
  Therapeutic efficacy of RDP58 combined with a lack of bioavailibility and toxicity suggest that RDP58 may be a promising new therapeutic for IBD.
authors.affiliation: Division of Gastroenterology and Hepatology, Drexel University College of Medicine, 245 N 15th Street, Philadelphia, PA 19102-1192, USA, s.Murthy@drexel.edu
authors.forename: S
authors.initials: S
authors.lastname: Murthy
authors.forename: A
authors.initials: A
authors.lastname: Flanigan
authors.forename: D
authors.initials: D
authors.lastname: Coppola
authors.forename: R
authors.initials: R
authors.lastname: Buelow
mesh_terms: D000818:Animals; D001682:Biological Availability; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D003106:Colon / Q000473:pathology; D016264:Dextran Sulfate; D004285:Dogs; D005243:Feces / Q000166:cytology; D005260:Female; D008253:Macaca mulatta; D051379:Mice; D009780:Occult Blood; D010455:Peptides / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity; D014018:Tissue Distribution; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D010455:Peptides; D014409:Tumor Necrosis Factor-alpha; C092373:allotrap; D016264:Dextran Sulfate